Dr. George Matthaiolampakis |
||
Dr. George Matthaiolampakis |
||
Biography |
||
Dr. George Matthaiolampakis has a Bachelor’s degree on Chemical Engineering from the National Technical University of Athens and received his Ph.D. from the School of Pharmacy at the University of Patras. Dr. Matthaiolampakis worked as a post-doctoral associate for two years at the NCI Center of Cancer Nanotechnology, Department of Pharmaceutical Sciences, School of Pharmacy, at Northeastern University. Prior to Northeastern University, the he worked for four years as a post-doctoral associate at the Division of Cancer Prevention, School of Medicine, at Stony Brook University. Dr. Matthaiolampakis is currently working as an Assistant Professor (tenure track) of Pharmaceutics at the Department of Basic Pharmaceutical Sciences, School of Pharmacy, at the University of Louisiana at Monroe. His lab is interested in using polymer-based nanomedicine to promote scientific knowledge in cancer treatment by integrating nanotechnology, imaging science, gene therapy and cancer biology. Based on pharmaceutical sciences, his research focus expands to mechanistic studies of compounds and nucleic acids, for gene regulation and treatment on a panel of diseases. His immediate research projects involve: 1) The use of siRNAs or miRNAs to regulate gene expression of key anti-apoptotic genes to inhibit chemoresistance and metastasis in lung and pancreatic cancer. 2) Utilization of nanotechnology for targeted delivery 3) Formulation design for crossing the Blood Brain Barrier and treatment of glioblastoma multiform for delivery of therapeutic compounds |
||
Research Interest |
||
Drug Delivery |
||
Certificate | ||